e-Consultation with Hepatologists

Professional statement

Dr Phillip Harrison is an internationally recognised London-based physician and one of the UK's leading specialists in hepatology and liver diseases. He specialises in abnormal liver functions, viral hepatitis, liver transplantation and interventional endoscopy, specifically ERCP. As chair of the NICE cirrhosis guideline development group, he is at the forefront of liver disease research and has written prolifically for numerous newspapers, as well as appearing on national television to draw public attention to the dangers of liver disease. His practice is based at the prestigious London Liver Centre, London Bridge Hospital, where he works alongside a team of some of the country's best specialists in this field, attracting patients from all over the UK, Europe, the Middle East, and Asia. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Andrew Peter Holt is a leading consultant hepatologist and gastroenterologist, based in Birmingham. Specialising in the treatment and management of complex liver disease and in liver transplantation, he sees patients with a wide range of liver conditions from his private clinics across Birmingham, where he offers such treatments as endoscopic therapy for liver related bowel problems, and AlfaPump therapy. Originally training and being registered with GMC in gastroenterology and general internal medicine, he specialised in liver disease, and has worked as a consultant in the Liver Unit since 2008.  Alongside his clinical practice, Dr Andrew Peter Holt is involved in a number of committees and steering groups, dedicated to improving outcomes for patients with different kinds of liver disease, and is chair of the Liver Transplant Board. He is dedicated to teaching, and is a senior lecturer in medicine at the University of Birmingham, along with publishing numerous peer-reviewed articles in medical journals in his medical field. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Matthew Foxton is a highly experienced consultant hepatologist and gastroenterologist with private clinics at Chelsea and Westminster Hospital, Chelsea Outpatient Centre and Chiswick Medical Centre. Among his areas of expertise are the treatment of fatty liver disease and hepatitis, using FibroScan, endoscopies and interpreting abnormal liver function tests.  Dr Foxton qualified from St George’s Hospital Medical School in 1995 and undertook specialist training in gastroenterology in South East London, where he gained sub-speciality accreditation in hepatology in 2007. He was awarded an MD from the University of London in 2009, following the submission of his thesis on hepatitis C recurrence after liver transplantation. Dr Foxton was appointed as gastroenterology consultant at Queen Elizabeth Hospital, Woolwich in 2007 and took up a post as consultant hepatologist at Chelsea and Westminster Hospital and King's College Hospital in 2010. In 2011 he became a Fellow of the Royal College of Physicians. He has a particular interest in new treatments for viral hepatitis, early detection of liver disease and hepatocellular carcinoma. He has contributed to numerous publications, some of which can be seen on PubMed. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Professor Kevin Moore is one of London's leading and most reputable liver specialists. He is Professor of Hepatology at University College London (UCL) and sees and treats all forms of liver disease at the Royal Free London Foundation Trust.  For twenty years, he was an integral part of the liver transplant team which lead the treatment of cirrhosis complications. Professor Moore sees patients with a wide variety of liver problems from abnormal liver function tests to advanced cirrhosis.  He currently leads the Alcohol Care Team at the Royal Free London NHS Foundation Trust and treats patients with alcohol dependency and alcohol-related liver problems, as well as fatty liver disease, autoimmune liver disease and cirrhosis. Professor Moore chaired the writing of the National Plan for Liver Services in 2010, has published two books in acute medicine (Oxford Handbook of Acute Medicine and the Oxford Desk Reference), and has been widely published in numerous peer-reviewed journals. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Jude Oben is a leading consultant hepatologist based in London who holds additional consultant appointments in gastroenterology. His areas of hepatology expertise include autoimmune liver disease, primary biliary cholangitis, primary sclerosis cholangitis, hepatocellular cancer, obesity, non-alcoholic fatty liver disease (NAFLD), abnormal liver function test and endoscopy and metabolic endoscopy (Intra-gastric balloon) for weight loss. Dr Oben has a PhD in Pharmacology from University College London. He studied Medicine at Oxford with a period at Stanford University, Palo Alto, USA, as a research fellow in Immunology. After Oxford, his initial Postgraduate Medical training was at the Hammersmith Hospital, Imperial College London, followed by training in Ophthalmology (Eye Surgery) which he left for Hepatology (Liver Medicine). During his specialist medical registrar training, he re-oriented his research career with two years as a postdoctoral fellow at John Hopkins University, USA. At Johns Hopkins, Dr Oben combined his previous interest in neuroscience with liver medicine, with a particular focus on obesity-related liver disease (NAFLD). After his time at John Hopkins, he was awarded a Wellcome Trust Fellowship in London to start independent research at University College London. He is currently an Associate Professor in Hepatology at University College London, Institute for Liver and Digestive Health, Royal Free Hospital, London. Dr Oben is a co-founder and Trustee of the Obesity Action launched at the House of Lords. The primary aim of Obesity Action is to raise political and public awareness of obesity and it’s health consequences. He is an invited member of the All-Party Parliamentary Group on Obesity.

*Translated with Google translator. We apologize for any imperfection